GlassScriptPhysician profile
Olivia Green
NPI 1295475051
$3,910.55
in general payments reported to CMS, 2019-2025
12 companies · $1,552 in 2025
The $1,552 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $385 · 2023: $834 · 2024: $1,139 · 2025: $1,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,525.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,719.06 | 2022-2025 | Ams 700, Accolade Sr, Moses 550 Dfl |
| Olympus America INC. | $701.61 | 2023-2025 | Itind System |
| Coloplast Corp | $615.43 | 2023-2025 | Peristeen |
| Calyxo, INC. | $150.00 | 2025 | Cvac Aspiration System |
| Convatec INC. | $142.00 | 2025 | |
| Antares Pharma, INC. | $124.99 | 2022 | |
| Endo Pharmaceuticals INC. | $124.85 | 2023 | Xiaflex |
| Myovant Sciences INC. | $118.99 | 2022 | |
| Photocure INC | $65.20 | 2024 | Cysview |
| Progenics Pharmaceuticals, INC. | $63.72 | 2023 | Pylarify |
| Medtronic, INC. | $63.52 | 2023 | Interstim |
| Sumitomo Pharma America, INC. | $21.18 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.